The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Regulatory News (EML)

Share Price Information for Emmerson (EML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.90
Bid: 1.80
Ask: 2.00
Change: -0.10 (-5.00%)
Spread: 0.20 (11.111%)
Open: 2.00
High: 1.95
Low: 1.90
Prev. Close: 2.00
EML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Options Scheme & Director Shareholdings

22 Jul 2022 09:00

RNS Number : 4357T
Emmerson PLC
22 July 2022
 

 

 

Emmerson PLC / Ticker: EML / Index: AIM / Sector: Mining

22 July 2022

Emmerson PLC ("Emmerson" or the "Company")

 

Approval of Employee Share Option Scheme, Grant of Share Options and Allotment of Shares to Directors/PDMRs

 

Emmerson, which is developing the world class Khemisset Potash Project in Morocco, is pleased to make the following announcements:

 

Approval of Employee Share Option scheme

 

As part of ongoing enhancements to corporate governance and remuneration, the Company yesterday adopted an Employee Share Option scheme. This scheme provides a framework for the award of future share options to eligible employees, and will include awards to be made, where appropriate, under the HMRC-approved Enterprise Management Incentive scheme.

 

Award of Share Options

 

On 21 July 2022, 6,013,000 share options were granted to employees and eligible contractors, including the CEO Graham Clarke (a PDMR) at an exercise price of 7 pence per share (the mid-market close price at the day prior to the award) as per the following table:

 

Director / Senior Management

New Options

Exercise price

Grant date

Vesting Date

Graham Clarke

1,821,000

7 pence

21 July 2022

20 July 2024

Other staff and contractors

4,192,000

7 pence

21 July 2022

20 July 2024

Total

6,013,000

 

 

 

 

These awards were made in recognition of performance during 2021. Following these awards, Graham Clarke holds 19,321,000 share options.

 

Allotment of New Ordinary Shares to Directors

 

As part of their remuneration package as Non-executive Directors, Rupert Joy and James Kelly are entitled to receive shares to the value of £10,000 and £20,000 respectively each year, based on the 10-day VWAP prior to the date of allotment, and pro rated since their dates of appointment in 2021. Accordingly, 66,371 new ordinary shares will be allotted to Rupert Joy and 218,406 new ordinary shares to James Kelly.

 

Director / Senior Management

Ordinary Shares allotted

Total shareholding after allotment

% of shares in issue

Rupert Joy

66,371

356,371

0.039%

James Kelly

218,406

968,406

0.106%

Total

284,777

 

 

 

 

The Company has applied for the 284,777 new shares to be admitted for trading on the AIM Market and admission is expected to take place on 27 July 2022.

 

Following this allotment, the total number of shares in issue will be 916,080,771.

 

**ENDS**

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact:

 

Emmerson PLC

Graham Clarke / Jim Wynn / Charles Vaughan

 

 

+44 (0) 20 7236 1177

 

 

Shore Capital (Nominated Adviser and Joint Broker)

Toby Gibbs / John More

 

 

+44 (0)20 7408 4090

 

 

 

Liberum Capital Limited (Joint Broker)

Scott Mathieson / Lydia Zychowska

+44 (0)20 3100 2000

Shard Capital (Joint Broker)

Damon Heath / Isabella Pierre

 

 

+44 (0)20 7186 9927

 

 

St Brides Partners (Financial PR/IR)

Susie Geliher / Charlotte Page

 

 

+44 (0)20 7236 1177

 

 

Notes to Editors

Emmerson is focused on advancing the Khemisset project ("Khemisset" or the "Project") in Morocco into a low cost, high margin supplier of potash, and the first primary producer on the African continent. With an initial 19-year life of mine, the development of Khemisset is expected to deliver long-term investment and financial contributions to Morocco including the creation of permanent employment, taxation and a plethora of ancillary benefits. As a UK-Moroccan partnership, the Company is committed to bringing in significant international investment over the life of the mine.

 

Morocco is widely recognised as one of the leading phosphate producers globally, ranking third in the world in terms of tonnes produced annually, and the development of this mine is set to consolidate its position as the most important fertiliser producer in Africa. The Project has a large JORC Resource Estimate (2012) of 537Mt @ 9.24% K2O, with significant exploration potential, and is perfectly located to support the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. The need to feed the world's rapidly increasing population is driving demand for potash and Khemisset is well placed to benefit from the opportunities this presents. The Feasibility Study released in June 2020 indicated the Project has the potential to be among the lowest capital cost development stage potash projects in the world and also, as a result of its location, one of the highest margin projects. This delivered outstanding economics, including a post-tax NPV8 of approximately US$1.4 billion using industry expert Argus' price forecasts, and the spot price for granular MOP fertiliser has since risen, further enhancing the valuations.

 

 

 

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Graham Clarke

2. 

Reason for the notification

a)

Position/status:

CEO

b)

Initial notification/Amendment:

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Emmerson PLC

b)

LEI:

213800JA8ZK1K6CWYP61

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of NPV 

 

ISIN: IM00BDHDTX83

 

b)

Nature of the transaction:

Grant of Options

c)

Price(s) and volume(s):

 

Volume Price (£)

1,821,000  0.07

d)

Aggregated information:

Aggregated volume:

Price:

 

n/a 

e)

Date of the transaction:

21 July 2022

f)

Place of the transaction:

Outside a trading Venue

 

 

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

1. James Kelly

2. Rupert Joy

2. 

Reason for the notification

a)

Position/status:

1. Non-Executive Chairman

2. Non-Executive Director

b)

Initial notification/Amendment:

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Emmerson PLC

b)

LEI:

213800JA8ZK1K6CWYP61

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of NPV 

 

ISIN: IM00BDHDTX83

 

b)

Nature of the transaction:

Grant of Ordinary Shares

c)

Price(s) and volume(s):

 

Volume Price (£)

1. 218,406 0.07

2. 66,371 0.07

 

d)

Aggregated information:

Aggregated volume:

Price:

 

284,777

0.07

 

e)

Date of the transaction:

21 July 2022

f)

Place of the transaction:

Outside a trading Venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUPCMUPPUMP
Date   Source Headline
12th Nov 20217:00 amRNSInvestor Presentation
11th Nov 202110:30 amRNSNotice of AGM
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20219:05 amRNSSecond Price Monitoring Extn
10th Nov 20219:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSStrategic Investment of up to US$46.75m
30th Sep 20217:01 amRNSOperational Update: Khemisset Potash Project
30th Sep 20217:00 amRNSInterim Results
12th Jul 20217:00 amRNSAppointment of Non-Exec Director & Board Changes
24th Jun 20217:00 amRNSKhemisset Potash Project Update
4th Jun 202111:30 amRNSDirector/PDMR Shareholding
3rd Jun 20212:05 pmRNSSecond Price Monitoring Extn
3rd Jun 20212:00 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSExercise of Warrants and Issue of Shares
21st May 20218:15 amRNSShareholder Call
18th May 20211:15 pmEQSHardman & Co Research: Emmerson Plc (EML): A competitively well-placed potash play
17th May 20217:00 amRNSFinal Results
29th Apr 202111:00 amRNSYellowstone Advisory Event
27th Apr 202112:40 pmEQSHardman & Co Research : Hardman & Co Video Event | Emmerson Plc - Investor Forum
27th Apr 20217:00 amRNSAdmission to AIM and Appointment of Chairman
21st Apr 20211:32 pmRNSSchedule One update - Emmerson plc
15th Apr 20217:00 amRNSUpdate on Phased Development Strategy
12th Apr 20217:00 amRNSExercise of Warrants and Issue of Shares
1st Apr 20211:30 pmRNSLondon South East Investor Webinar
31st Mar 20219:20 amRNSDirector/PDMR Shareholding
26th Mar 20218:00 amRNSSchedule One - Emmerson plc
26th Mar 20217:00 amRNSApplication for Admission to AIM
25th Mar 20212:00 pmRNSResult of GM, Retirement of Non-executive Chairman
24th Mar 20218:00 amRNSAllotment of Shares
23rd Mar 20217:00 amRNSExperienced Non-Executive Director Joins the Board
11th Mar 20217:00 amRNSShareholder Newsletter
2nd Mar 20217:00 amRNSIntention to list on AIM & Notice of GM
26th Feb 20216:29 pmRNSResult of Placing
26th Feb 20214:35 pmRNSProposed placing to raise £5.25 to £5.75 million
17th Feb 20217:00 amRNSPhased Development and Expansion Assessment
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:01 pmRNSPrice Monitoring Extension
9th Feb 202111:06 amRNSSecond Price Monitoring Extn
9th Feb 202111:00 amRNSPrice Monitoring Extension
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSMining Licence Approved for the Khemisset Project
28th Jan 20217:00 amRNS2020 Sustainability Brief
21st Jan 20219:00 amRNSInvestor Presentation
19th Jan 20217:00 amRNSExercise of Warrants and Issue of Shares
18th Jan 20212:05 pmRNSSecond Price Monitoring Extn
18th Jan 20212:00 pmRNSPrice Monitoring Extension
11th Jan 20212:05 pmRNSSecond Price Monitoring Extn
11th Jan 20212:00 pmRNSPrice Monitoring Extension
8th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.